Axillary dissection in breast-conserving surgery for stage I and II breast cancer: A National Cancer Data Base study of patterns of omission and implications for survival

Journal of the American College of Surgeons

Volumn 188, Issue 6, 1999, Pages 586-595

  Bland, Kirby I ^a   Scott Conner, Carol E H ^b   Menck, Herman ^c   Winchester, David P ^d,e  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c AMERICAN COLLEGE OF SURGEONS   (United States)

^d EVANSTON HOSPITAL   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CONTROL; CANCER STAGING; CANCER SURVIVAL; CHRONIC PAIN; FEMALE; FROZEN SHOULDER; HUMAN; LIFE EXPECTANCY; LYMPHADENECTOMY; LYMPHEDEMA; NERVE INJURY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0033041068     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(99)00056-3     Document Type: Article

References (26)

1. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985;5:17-21.
2. Fisher B, Bauer M, Margolese R, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. New Engl J Med 1985;312:665-673.
3. Winchester DJ, Menck HR, Winchester DP. The National Cancer Data Base Report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy. Cancer 1997;80:162-167.
4. Bland KI, Menck HR, Scott-Conner CEH, et al. The National Cancer Data Base 10-Year Survey of Breast Carcinoma Treatment at Hospitals in the United States. Cancer 1998;83:1262-1273.
5. Winchester DP, Osteen RT, Menck HR. The National Cancer Data Base Report on breast carcinoma characteristics and outcome in relation to age. Cancer 1996;78:1838-1843.
6. Shambaugh E, Young JL, Zippin C, et al. Statistics and Epidemiology for Cancer Registrars, Self-instructional Manual for Cancer Registrars, Book 7. Surveillance Epidemiology and End Results Program, Bethesda, MD: National Institutes of Health, 1995.
7. Reintgen DS, Cox CE, Puleo CA. Lymphedema in the postmastectomy patient: pathophysiology, prevention, and management. In: Bland KI, Copeland EM eds. The Breast: Comprehensive Management of Benign and Malignant Diseases (2nd edition), Philadelphia: WB Saunders, 1998:1003-1011.
8. Fisher B, Montague E, Redmond C, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer: a first report of results from a prospective randomized clinical trial. Cancer 1977;39:2827-2839.
9. Busch E, Kemeny M, Fremgen A, et al. Patterns of breast cancer care in the elderly. Cancer 1996;78:101-111.
10. Samet JM, Hunt WC, Farrow DC. Determinants of receiving breast-conserving surgery. The Surveillance, Epidemiology, and End Results Program, 1983-1986. Cancer 1994;73:2344-2351.
11. Lazavich DA, White E, Thomas DB, Moe RE. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991;266:3433-3438.
12. Margolese RG. Axillary surgery in breast cancer - there still is a debate. Eur J Cancer 1993;29A,801.
13. Halverson KJ, Taylor ME, Perez CA, et al. Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 1994;17:461-466.
14. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Cancer 1994;73:664-667.
15. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 1994;73:505-508.
16. Recht A, Pierce SM, Abner A, et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991;9:988-996.
17. Hand R, Sener S, Imperato J, et al. Hospital variables associated with quality of care for breast cancer patients. JAMA 1991;266: 3429-3432.
18. Roohan PJ, Bickell NA, Baptiste MS, et al. Hospital volume differences and five-year survival from breast cancer. Am J Public Health 1998;88:454-457.
19. Goodwin JS, Freeman JL, Freeman D, Nattinger AB. Geographic variations in breast cancer mortality: do higher rates imply elevated incidence or poorer survival? Am J Public Health 1998;88: 458-460.
20. Greenfield S, Blanco DM, Elashof RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA 1987;257:2766-2770.
21. th edition), Washington DC: US Government Printing House, 1996:89.
22. Pack MS, Thomas RS. Axillary lymph node dissection: does it have a role in primary breast cancer? Amer Surg 1996;62:159-161.
23. Cabanes PA, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992;339:1245-1248.
24. White RE, Vezeridis MP, Knostadoulakis M, et al. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg 1996;183:575-582.
25. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg One 1999;6:109-116.
26. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. New Engl J Med 1998;339:941-946.